Can Vibrational Spectroscopy Track Type 2 Diabetes?

Recently, it has been explored how vibrational spectroscopy can identify molecular changes in red blood cells caused by type 2 diabetes. By using Fourier transform infrared (FT-IR) and Raman spectroscopy, researchers are discovering how to detect early signs of protein misfolding, lipid remodeling, and oxidative stress, providing a label-free and non-invasive method for staging disease progression by tracking structural shifts in cell membranes.

In this Q&A overview, we explore how vibrational spectroscopy is set to help create a robust framework for identifying complex biomarkers that traditional blood tests might overlook.

How does vibrational spectroscopy identify molecular alterations in red blood cells (RBCs) caused by type 2 Diabetes mellitus (T2DM)?

Vibrational spectroscopy, specifically FT-IR) and Raman spectroscopy, provides a label-free, non-invasive "fingerprint" of the biochemical state of red blood cells (RBCs).^1,2 These techniques detect changes in molecular vibrations associated with specific chemical bonds, allowing researchers to monitor protein conformation, lipid remodeling, and oxidative stress simultaneously.^1,2 In the context of T2DM, these methods reveal how chronic hyperglycaemia and oxidative stress lead to protein misfolding, membrane destabilization, and increased rigidity in RBCs.^1,2

What specific role does FT-IR spectroscopy play in detecting protein changes in diabetic RBCs?

FT-IR spectroscopy is exceptionally sensitive to protein secondary structure.¹ This means the technique can distinguish between α-helix, β-sheet, and β-turn structures by analyzing the Amide I and Amide II bands, which are modulated by distinct hydrogen-bonding geometries and transition dipole couplings within the peptide backbone.¹ In diabetic samples, researchers observe a characteristic shift from α-helical conformations toward increased β-sheet and β-turn content, a hallmark of protein misfolding and early aggregation.¹ Because raw FT-IR spectra often contain broad, overlapping bands, it requires using second-derivative data preprocessing. This preprocess helps sharpen individual band components, which ultimately reveals subtle conformational changes that would otherwise have remained hidden.¹

How does Raman spectroscopy complement FT-IR in these studies?

Raman spectroscopy and FT-IR spectroscopy cover for the other’s limitations. For example, Raman spectroscopy can offer access to vibrational modes that are often weak or inactive in IR, such as symmetric bonds and disulfide bridges.¹ It is particularly effective for probing oxidative stress and lipid organization because it is far less affected by water interference than FT-IR, making it ideal for hydrated biological samples.¹ Raman spectroscopy can directly probe the 544 cm⁻¹ band assigned to disulfide bonds, which serves as a sensitive indicator of protein folding integrity and redox balance.² Therefore, these two techniques have a symbiotic relationship with one another. While FT-IR excels at tracking protein secondary structure, Raman spectroscopy provides the necessary sensitivity to lipid remodeling and oxidative damage.¹

What are the primary molecular markers of disease progression from early to advanced T2DM?

As T2DM progresses, the spectroscopic transition is characterized by a gradual shift from α-helix-rich, fluid membranes toward β-rich aggregated protein conformations and rigid lipid bilayers.³ Early stages may show only moderate increases in β-sheet content, suggesting that destabilization begins before extensive aggregation is apparent.³ In advanced stages, particularly in older subjects, the Amide I band broadens and shifts significantly. This observation reflects an increased conformational heterogeneity and the presence of misfolded protein assemblies.³ Additionally, a decrease in the ratio of unsaturated to saturated lipids indicates tighter lipid packing and reduced membrane fluidity. These two variables ultimately impair the cell's mechanical flexibility.³

Why is it necessary to isolate RBC membranes when using Raman spectroscopy?

A significant challenge in Raman spectroscopy of intact RBCs is that the signal is overwhelmingly dominated by hemoglobin.² The heme chromophore exhibits strong resonance enhancement, which masks the much weaker signals from membrane lipids and proteins.² To extract clear biochemical information about the membrane matrix, researchers must often use isolated membranes where the hemoglobin contribution is removed.² Conversely, FT-IR spectroscopy is not dominated by hemoglobin effects, allowing it to be used on intact RBCs for a more balanced assessment of both cytosolic and membrane features.² This makes FT-IR a more practical candidate for future clinical applications.

How do age and sex (gender) influence the spectroscopic signatures of diabetic RBCs?

Research indicates that sex-specific analysis is essential because the susceptibility of RBCs to metabolic stress differs significantly between males and females.³ In studies of the db/db mouse model (a leptin receptor–deficient model of type 2 diabetes), diabetes-induced molecular remodeling, including protein aggregation and lipid changes, was found to be more pronounced in female-derived RBCs, especially at advanced stages.³ Age further amplifies these effects through the cumulative impact of oxidative damage and glycation.³ Consequently, vibrational spectra act as integrated readouts of biological aging, sex-dependent regulation, and disease state, requiring researchers to stratify data to avoid masking subgroup-specific biomarkers.³ Therefore, both age and sex are important variables that could influence the spectroscopic signatures.

How is complex spectral data processed to identify reliable biomarkers?

Because biochemical information is spread across numerous correlated wavenumbers, researchers use multivariate approaches like orthogonal partial least squares discriminant analysis (oPLS-DA).² This method separates variance linked to the disease from noise and biological heterogeneity.² A critical tool in this process is the variable importance in projection (VIP) score, which identifies the most influential wavenumbers driving the model.² High-VIP regions can then be correlated with specific molecular vibrations, such as those related to protein aggregation or lipid saturation, facilitating the transition from statistical data to biologically meaningful biomarkers.²

What are the limitations of translating these findings from mouse models to human diagnostics?

Several hurdles remain for human translation. A recent study presented a mouse model driven by a specific leptin receptor mutation that may not capture the full heterogeneity of human T2DM.³ Furthermore, there are species-specific differences in RBC metabolic activity and lipid handling that complicate direct extrapolation.³ Future clinical implementation will require standardization of instrumentation, large-scale validation in human cohorts, and the integration of artificial intelligence (AI)-enabled analytical pipelines.³

References

1. Marzac, K.; Perez-Guaita, D.; Wajda, A.; et al. Sex- and Age-Dependent Red Blood Cell Remodeling in Type 2 Diabetes Revealed by FT-IR and Raman Spectroscopy: Part I. Spectroscopy. Available at: https://www.spectroscopyonline.com/view/sex--and-age-dependent-red-blood-cell-remodeling-in-type-2-diabetes-revealed-by-ft-ir-and-raman-spectroscopy-part-i (accessed 2026-03-19).
2. Marzac, K.; Perez-Guaita, D.; Wajda, A.; et al. Sex- and Age-Dependent Red Blood Cell Remodeling in Type 2 Diabetes Revealed by FT-IR and Raman Spectroscopy: Part II. Spectroscopy. Available at: https://www.spectroscopyonline.com/view/sex--and-age-dependent-red-blood-cell-remodeling-in-type-2-diabetes-revealed-by-ft-ir-and-raman-spectroscopy-part-ii (accessed 2026-03-19).
3. Marzac, K.; Perez-Guaita, D.; Wajda, A.; et al. Sex- and Age-Dependent Red Blood Cell Remodeling in Type 2 Diabetes Revealed by FT-IR and Raman Spectroscopy: Part III. Spectroscopy. Available at: https://www.spectroscopyonline.com/view/sex--and-age-dependent-red-blood-cell-remodeling-in-type-2-diabetes-revealed-by-ft-ir-and-raman-spectroscopy-part-iii (accessed 2026-03-19).